Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease

This study has been completed.
Sponsor:
Information provided by:
Noscira SA
ClinicalTrials.gov Identifier:
NCT00948259
First received: July 27, 2009
Last updated: November 10, 2009
Last verified: November 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)